Increased sales of both new drugs and old brands retained a lower demand for medical equipment and healthcare products.
But it was not enough for the pharmaceutical and healthcare group Johnson & amp; Johnson, who reported a lower profit for the fourth quarter of 2014, compared with the same period a year earlier.
The profit before tax fell to $ 2.5 billion, or 0.89 dollars per share, from 3.5 billion, or 1:23 dollars per share in 2013.
Excluding one-time items, earnings 1:27 dollars per share, which was marginally better than analysts had expected.
sales fell more than half a percent to 18.25 billion dollars.
No comments:
Post a Comment